Patents by Inventor Francesco Scarci

Francesco Scarci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of pidotimod to treat irritable bowel syndrome
    Patent number: 9446027
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: September 20, 2016
    Assignee: POLICHEM SA
    Inventors: Federico Mailland, Francesco Scarci, Maurizio Caserini
  • Use of pidotimod to treat irritable bowel syndrome
    Patent number: 9408833
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: August 9, 2016
    Assignee: POLICHEM SA
    Inventors: Federico Mailland, Francesco Scarci, Maurizio Caserini
  • COMPOSITION FOR SKIN ANTI-AGEING TREATMENT
    Publication number: 20160175241
    Abstract: The present invention is directed to a composition comprising an extract of Humulus lupulus combined with hyaluronic acid and a C1-C4 alkanol, and to its use as an anti-ageing treatment for the skin of human being. For the use of the present invention, the new composition is administered topically.
    Type: Application
    Filed: August 4, 2014
    Publication date: June 23, 2016
    Inventors: Francesco SCARCI, Giuliana IOB, Federico MAILLAND
  • USE OF PIDOTIMOD TO TREAT INFLAMMATORY BOWEL DISEASE
    Publication number: 20160058739
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat inflammatory bowel disease. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
    Type: Application
    Filed: April 5, 2013
    Publication date: March 3, 2016
    Inventors: Federico Mailland, Francesco Scarci, Maurizio Caserini
  • USE OF PIDOTIMOD TO TREAT IRRITABLE BOWEL SYNDROME
    Publication number: 20160058740
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
    Type: Application
    Filed: April 5, 2013
    Publication date: March 3, 2016
    Inventors: Federico Mailland, Francesco Scarci, Maurizio Caserini